Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study-Reference-Cited by-同舟云学术

Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study

Published:2015-03-02 Issue:5 Volume:169 Page:672-682
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ishida Takashi¹,Jo Tatsuro²,Takemoto Shigeki³,Suzushima Hitoshi⁴,Uozumi Kimiharu⁵,Yamamoto Kazuhito⁶,Uike Naokuni⁷,Saburi Yoshio⁸,Nosaka Kisato⁹,Utsunomiya Atae¹⁰,Tobinai Kensei¹¹,Fujiwara Hiroshi¹²,Ishitsuka Kenji¹³,Yoshida Shinichiro¹⁴,Taira Naoya¹⁵,Moriuchi Yukiyoshi¹⁶,Imada Kazunori¹⁷,Miyamoto Toshihiro¹⁸,Akinaga Shiro¹⁹,Tomonaga Masao²,Ueda Ryuzo²⁰

Affiliation:

1. Department of Haematology and Oncology Nagoya City University Graduate School of Medical Sciences NagoyaJapan

2. Department of Haematology Japanese Red Cross Nagasaki Genbaku Hospital NagasakiJapan

3. Department of Haematology and Institute for Clinical Research National Hospital Organization Kumamoto Medical CentreKumamoto Japan

4. Department of Haematology Kumamoto Shinto General Hospital KumamotoJapan

5. Department of Haematology and Immunology Kagoshima University Hospital KagoshimaJapan

6. Department of Haematology and Cell Therapy Aichi Cancer Centre Hospital NagoyaJapan

7. Department of Haematology National Hospital Organization Kyushu Cancer Centre FukuokaJapan

8. Department of Haematology Oita Prefectural Hospital OitaJapan

9. Cancer Centre Kumamoto University Hospital KumamotoJapan

10. Department of Haematology Imamura Bun‐in Hospital KagoshimaJapan

11. Department of Haematology National Cancer Centre Hospital TokyoJapan

12. Department of Bioregulatory Medicine Ehime University Graduate School of Medicine ToonJapan

13. Division of Medical Oncology, Haematology, and Infectious Diseases Department of Internal Medicine Fukuoka University FukuokaJapan

14. Department of Haematology National Hospital Organization Nagasaki Medical Centre OhmuraJapan

15. Department of Internal Medicine Heartlife Hospital OkinawaJapan

16. Department of Haematology Sasebo City General Hospital SaseboJapan

17. Department of Haematology Kokura Memorial Hospital KitakyushuJapan

18. Department of Medicine and Biosystemic Science Kyushu University Graduate School of Medical Sciences FukuokaJapan

19. Kyowa Hakko Kirin Co., Ltd. Tokyo Japan

20. Department of Tumour Immunology Aichi Medical University School of Medicine Nagoya Japan

Funder

Kyowa Hakko Kirin Co., Ltd.,

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.13338

Reference30 articles.

1. Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT)

2. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study

3. Immunopathogenesis of lymphoma: Focus on CCR4

4. Clinical significance of CCR4 expression in adult T‐cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome;Ishida T.;Clinical Cancer Research,2003

5. CXC Chemokine Receptor 3 and CC Chemokine Receptor 4 Expression in T-Cell and NK-Cell Lymphomas with Special Reference to Clinicopathological Significance for Peripheral T-Cell Lymphoma, Unspecified

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL17, CCL22 and their receptor CCR4 in hematologic malignancies;Discover Oncology;2024-09-06

2. Atypical Presentation of Invasive Aspergillosis during Treatment with Mogamulizumab;Journal of Fungi;2024-08-17

3. Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan;Hematological Oncology;2024-06-07

4. Pooled analysis of pralatrexate single-agent studies in patients with relapsed/refractory peripheral T-cell lymphoma;Blood Advances;2024-05-29

5. Fulminant hepatitis in a hepatitis B surface antigen‐positive patient with adult T‐cell leukemia‐lymphoma after mogamulizumab monotherapy;Hepatology Research;2024-05-21